GLP-1 RAs are being studied [archived link] for use in many other medical conditions, including fatty liver disease, Parkinsons disease, and substance use disorders, among others
The BALANCE model would have allowed Part D plans to opt into the program to provide coverage for GLP-1 drugs for weight loss for their enrollees
Collectively, the benefits generally outweigh the risks, making it an intriguing option for those seeking advanced weight loss therapies
Elvert R, Herling AW, Bossart M, Weiss T, Zhang B, Wenski P, et al
If you have concerns about medication detection for employment, insurance, or other purposes, discuss them openly with your healthcare provider
In addition, even if our results of operations, financial condition and liquidity, and developments in the industry in which we operate are consistent with the forward-looking statements contained in such reports, those results or developments may not be indicative of results or developments in subsequent periods